Abstract
Background A 29-year-old man presented to a clinic with infertility and hypogonadism in the setting of morbid obesity. On presentation, he had notable gynecomastia and a low testicular volume. The patient's weight was 154 kg and his height was 168 cm (BMI 54.5 kg/m2). Before referral to the clinic, the patient had been treated with testosterone therapy for 4 months for hypogonadism. This treatment had caused his initially low sperm concentration to fall to undetectable levels.
Investigations Measurement of reproductive hormone levels, pituitary MRI, and semen analysis.
Diagnosis Infertility secondary to hypogonadotropic hypogonadism and an elevated estrogen:testosterone ratio.
Management Treatment with an aromatase inhibitor, anastrozole, led to normalization of the patient's testosterone, luteinizing hormone and follicle-stimulating hormone levels, suppression of serum estradiol levels, and to normalization of spermatogenesis and fertility.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hammoud AO et al. (2006) Obesity and male reproductive potential. J Androl 27: 619–626
Raman JD and Schlegel PN (2002) Aromatase inhibitors for male infertility. J Urol 167: 624–629
Hull MG et al. (1985) Population study of causes, treatment, and outcome of infertility. Br Med J (Clin Res Ed) 291: 1693–1697
Jensen TK et al. (2004) Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertil Steril 82: 863–870
Hedley AA et al. (2004) Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291: 2847–2850
Aggerholm AS et al. (2007) Is overweight a risk factor for reduced semen quality and altered serum sex hormone profile? Fertil Steril [doi:10.1016/j.fertnstert.2007.07.1292]
Sallmen M et al. (2006) Reduced fertility among overweight and obese men. Epidemiology 17: 520–523
Hammoud AO et al. (2008) Male obesity and alteration in sperm parameters. Fertil Steril. [doi:10.1016/j.fertnstert.2007.10.011]
Nguyen RH et al. (2007) Men's body mass index and infertility. Hum Reprod 22: 2488–2493
Fejes I et al. (2006) Effect of body weight on testosterone/estradiol ratio in oligozoospermic patients. Arch Androl 52: 97–102
Raven G et al. (2006) In men, peripheral estradiol levels directly reflect the action of estrogens at the hypothalamo-pituitary level to inhibit gonadotropin secretion. J Clin Endocrinol Metab 91: 3324–3328
Sluss PM et al. (2008) Mass spectrometric and physiological validation of a sensitive, automated, direct immunoassay for serum estradiol using the Architect(R). Clin Chim Acta 388: 99–105
Snyder PJ et al. (2000) Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 85: 2670–2677
Bhasin S et al. (2006) Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 91: 1995–2010
Zumoff B et al. (2003) Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone. Metabolism 52: 1126–1128
de Boer H et al. (2005) Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism. Diabetes Obes Metab 7: 211–215
Acknowledgements
The authors thank WJ Bremner for helpful comments during the preparation of the manuscript. ST Page is supported, in part, by the National Institute of Aging, a Division of the NIH, by grant K23 AG027238. JK Amory is supported, in part, by the National Institute of Child Health and Human Development, a Division of the NIH, through grant K23 HD45386.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Roth, M., Amory, J. & Page, S. Treatment of male infertility secondary to morbid obesity. Nat Rev Endocrinol 4, 415–419 (2008). https://doi.org/10.1038/ncpendmet0844
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0844
This article is cited by
-
Male infertility
Nature Reviews Disease Primers (2023)
-
Effects of clomiphene citrate on male obesity-associated hypogonadism: a randomized, double-blind, placebo-controlled study
International Journal of Obesity (2018)